Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
TAVR Versus SAVR in Young, Low-risk Patients
Author(s): Quynh Nguyen , Jessica GY Luc , Thomas E MacGillivray , et al Added: 1 year ago

Vascular Disease and Surgery

Intervention
Current Strategies in the Management of Aortic Stenosis
Author(s): Anne H Tavenier , Johny Nicolas , Roxana Mehran Added: 1 year ago

Intervention
HFSA 22: PROVE-HF: Effect of Sacubitril/Valsartan in Patients with Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction
Author(s): James L Januzzi Added: 1 year ago
HFSA 22 - Dr James Januzzi (Massachusetts General Hospital, US) outlines the findings of the PROVE-HF study, a trial which aimed to determine the effect of sacubitril/valsartan therapy on cardiac biomarkers in patients with mitral regurgitation in heart failure with reduced ejection fraction. Questions: 1. What was the ideology behind PROVE-HF? 2. What is the mechanism of action behind… View more

Heart Failure
Dual Antiplatelet Regimens for TAVR and Cardiac CT Evaluation of Leaflets
Author(s): Mirvat Alasnag , Waqar Ahmed , Ibrahim Al-Nasser , et al Added: 2 years ago

Anticoagulation

Imaging & Diagnostics
TCT 22: 1Y Outcomes of Portico™ Valve in Pts with Severe Aortic Stenosis
Added: 1 year ago
TCT 22 - Prof Helge Möllmann joins us to discuss the findings of a study that aimed to evaluate the procedural safety and device performance of Abbott's Portico™ TAVI Valve in patients with severe symptomatic degenerative aortic stenosis. Originally presented at TCT 22, The CONFIDENCE Registry involved over 1000 patients with NYHA Class ≥ II Aortic Stenosis who received transcatheter aortic… View more

Intervention
Between a Rock and a Hard Place: How to Use Antithrombotics in Patients Undergoing Transcatheter Aortic Valve Replacement
Author(s): Mathew R Williams , Kelsey Grossman , Homam Ibrahim Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) has become the preferred method for management of severe aortic stenosis in patients who are at high and intermediate surgical risk. Short-term data have been presented from two studies comparing TAVR versus surgical aortic valve replacement (SAVR) in low surgical risk patients. The Placement of Aortic Transcatheter Valves 3 (PARTNER 3) trial compared… View more

Anticoagulation
Nicolo Piazza
Job title: Assistant Professor to the Cardiology Division
Dr. Nicolo Piazza, Assistant Professor to the Cardiology Division and Attending at the MUHC. Dr. Piazza earned his medical degree at McGill University, where he subsequently completed post-graduate training in Cardiology. He completed a one year interventional cardiology clinical fellowship at the Montreal Heart Institute and two subsequent fellowships – a two year PhD research fellowship in… View more
Vinayak Bapat
Job title: Surgical Director, Mitral and Tricuspid Therapies
Surgical Director, Mitral and Tricuspid Therapies at NewYork-Presbyterian/ Columbia University Medical Center. Dr. Bapat is also an assistant professor of surgery at CUMC.Dr. Bapat specializes in the minimally invasive and percutaneous treatment of structural heart disease with a focus on mitral and tricuspid therapies.Dr. Bapat did a fellowship program at Royal College of Surgeons in Edinburgh… View more
View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more

Intervention
Intrepid TMVR: Results Show Improved NYHA Class at 30 Days
Author(s): Firas Zahr Added: 2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral… View more

Intervention